Bluejay's lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD).
Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand.
Event of the Heart, which is the primary fundraiser for MCAVHN Care and Prevention Network takes place on Feb. 15 at the ...
We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...
Many readers wrote to express their strong opposition to Robert F. Kennedy Jr.’s nomination to head the Department of Health and Human Services, which this week cleared a Senate committee vote and ...
The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.
GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
HealthDay News — For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC), according to a review published online ...
New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.
The Louisiana Republican, who led a hepatitis B vaccination campaign before entering politics, has expressed concerns about ...
The Cancer Services Program: Any resident of Cayuga, Cortland or Tompkins counties looking for financial assistance with ...
Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...